Cost effectiveness of an aromatase inhibitor and recombinant FSH versus FSH alone in older patients undergoing intrauterine insemination.

被引：0
|
作者：
Bedaiwy, MA [1 ]
Forman, R [1 ]
Casper, RF [1 ]
机构：
[1] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
来源：
FERTILITY AND STERILITY | 2005年 / 84卷
关键词：
D O I：
10.1016/j.fertnstert.2005.07.101
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 36 条
  • [21] Cost-effectiveness modelling of recombinant FSH (r-hFSH) versus urinary FSH (u-hFSH) in assisted reproduction techniques (ART) in Germany
    Felberbaum, R
    Daya, S
    Fischer, R
    Thaele, M
    Auray, JP
    Duru, G
    Bouzayen, R
    Beresniak, A
    Blechschmidt, J
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2002, 62 (07) : 668 - 676
  • [22] Human Menopausal Gonadotropin versus Recombinant FSH in Polycystic Ovary Syndrome Patients Undergoing In Vitro Fertilization
    Turkcapar, Ayse Figen
    Seckin, Berna
    Onalan, Gogsen
    Ozdener, Tulin
    Batioglu, Sertac
    INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2013, 6 (04) : 238 - 243
  • [23] A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility
    Dankert, T.
    Kremer, J. A. M.
    Cohlen, B. J.
    Hamilton, C. J. C. M.
    Pasker-de Jong, P. C. M.
    Straatman, H.
    van Dop, P. A.
    HUMAN REPRODUCTION, 2007, 22 (03) : 792 - 797
  • [24] A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data
    Hatoum, HT
    Keye, WR
    Marrs, RP
    Walton, SM
    Marshall, DC
    FERTILITY AND STERILITY, 2005, 83 (03) : 804 - 807
  • [25] Recombinant versus urinary follicle-stimulating hormone in intrauterine insemination cycles: a prospective, randomized analysis of cost effectiveness
    Gerli, S
    Casini, ML
    Unfer, V
    Costabile, L
    Bini, V
    Di Renzo, GC
    FERTILITY AND STERILITY, 2004, 82 (03) : 573 - 578
  • [26] Overall Survival With Palbociclib and Aromatase Inhibitor Versus Aromatase Inhibitor Alone in Older Patients With HR+/HER2-Metastatic Breast Cancer
    Brufsky, Adam M.
    Sandin, Rickard
    Stergiopoulos, Stella
    Chen, Connie
    Karanth, Siddharth
    Li, Benjamin
    Esterberg, Elizabeth
    Makari, Doris
    Candrilli, Sean D.
    Goyal, Ravi K.
    Rugo, Hope S.
    CANCER MEDICINE, 2025, 14 (07):
  • [27] A prospective, randomized controlled trial comparing highly purified hMG with recombinat FSH plus recombinant LH in women undergoing intrauterine insemination: Ovarian response and clinical outcomes.
    Labarta, E.
    Bosch, E.
    Simon, C.
    Remohi, J.
    Pellicer, A.
    FERTILITY AND STERILITY, 2007, 88 : S295 - S296
  • [28] Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF
    Mennini, F. S.
    Marcellusi, A.
    Viti, R.
    Bini, C.
    Carosso, A.
    Revelli, A.
    Benedetto, C.
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2018, 16
  • [29] Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVF
    F. S. Mennini
    A. Marcellusi
    R. Viti
    C. Bini
    A. Carosso
    A. Revelli
    C. Benedetto
    Reproductive Biology and Endocrinology, 16
  • [30] Effectiveness of HP-hMG versus r-FSH in patients undergoing IVF/ICSI cycles with moderate male-factor infertility
    Turhan, Nilgun
    Pekel, Aslihan
    Ayrim, Aylin
    Kasap, Burcu
    Bayrak, Omer
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2013, 43 (01) : 144 - 149
1234